| R-HSA-1169408 |
ISG15 antiviral mechanism |
| R-HSA-1169410 |
Antiviral mechanism by IFN-stimulated genes |
| R-HSA-1280215 |
Cytokine Signaling in Immune system |
| R-HSA-1280218 |
Adaptive Immune System |
| R-HSA-141405 |
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| R-HSA-141430 |
Inactivation of APC/C via direct inhibition of the APC/C complex |
| R-HSA-1640170 |
Cell Cycle |
| R-HSA-1643685 |
Disease |
| R-HSA-168256 |
Immune System |
| R-HSA-174048 |
APC/C:Cdc20 mediated degradation of Cyclin B |
| R-HSA-174084 |
Autodegradation of Cdh1 by Cdh1:APC/C |
| R-HSA-174143 |
APC/C-mediated degradation of cell cycle proteins |
| R-HSA-174154 |
APC/C:Cdc20 mediated degradation of Securin |
| R-HSA-174178 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| R-HSA-174184 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A |
| R-HSA-176407 |
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| R-HSA-176408 |
Regulation of APC/C activators between G1/S and early anaphase |
| R-HSA-176409 |
APC/C:Cdc20 mediated degradation of mitotic proteins |
| R-HSA-176412 |
Phosphorylation of the APC/C |
| R-HSA-176814 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins |
| R-HSA-179409 |
APC-Cdc20 mediated degradation of Nek2A |
| R-HSA-179419 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint |
| R-HSA-212436 |
Generic Transcription Pathway |
| R-HSA-2262752 |
Cellular responses to stress |
| R-HSA-2467813 |
Separation of Sister Chromatids |
| R-HSA-2555396 |
Mitotic Metaphase and Anaphase |
| R-HSA-2559582 |
Senescence-Associated Secretory Phenotype (SASP) |
| R-HSA-2559583 |
Cellular Senescence |
| R-HSA-392499 |
Metabolism of proteins |
| R-HSA-453276 |
Regulation of mitotic cell cycle |
| R-HSA-597592 |
Post-translational protein modification |
| R-HSA-68882 |
Mitotic Anaphase |
| R-HSA-68886 |
M Phase |
| R-HSA-69017 |
CDK-mediated phosphorylation and removal of Cdc6 |
| R-HSA-69052 |
Switching of origins to a post-replicative state |
| R-HSA-69239 |
Synthesis of DNA |
| R-HSA-69242 |
S Phase |
| R-HSA-69278 |
Cell Cycle, Mitotic |
| R-HSA-69306 |
DNA Replication |
| R-HSA-69618 |
Mitotic Spindle Checkpoint |
| R-HSA-69620 |
Cell Cycle Checkpoints |
| R-HSA-73857 |
RNA Polymerase II Transcription |
| R-HSA-74160 |
Gene expression (Transcription) |
| R-HSA-8852135 |
Protein ubiquitination |
| R-HSA-8853884 |
Transcriptional Regulation by VENTX |
| R-HSA-8866652 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes |
| R-HSA-8866654 |
E3 ubiquitin ligases ubiquitinate target proteins |
| R-HSA-8953897 |
Cellular responses to external stimuli |
| R-HSA-913531 |
Interferon Signaling |
| R-HSA-9675126 |
Diseases of mitotic cell cycle |
| R-HSA-9687136 |
Aberrant regulation of mitotic exit in cancer due to RB1 defects |
| R-HSA-9687139 |
Aberrant regulation of mitotic cell cycle due to RB1 defects |
| R-HSA-983168 |
Antigen processing: Ubiquitination & Proteasome degradation |
| R-HSA-983169 |
Class I MHC mediated antigen processing & presentation |
